Table 10: Five year observed survival proportions (OSPs) and 95% confidence intervals (CIs) for children aged 0 to 14 years diagnosed with cancer by the International Classification of Childhood Cancer (ICCC-3) diagnostic groups and subgroups, 2001-2006, Canada (English, CSV)
Table 10: Five year observed survival proportions (OSPs) and 95% confidence intervals (CIs) for children aged 0 to 14 years diagnosed with cancer by the International Classification of Childhood Cancer (ICCC-3) diagnostic groups and subgroups, 2001-2006, Canada: English CSV file you can open as a table, filter, chart and export up to 10,000 rows. From Public Health Agency of Canada, updated Mar 2020.
- Format
- CSV
- Access
- Table on demand (prepared when opened)
- Publisher-reported update
- 2020-03-02
The Cancer in Young People in Canada (CYP-C) program is a national, population-based surveillance system that collects health and treatment information on each child/youth under the age of fifteen diagnosed with cancer in Canada. These datasets contain the information presented in the tables and figures describing the demographics, diagnosis, treatment, location and timing of care, and outcomes in children diagnosed with cancer from 2001-2006 which were published in the following report: The Public Health Agency of Canada. (2017). Cancer in Young People in Canada: A Report from the Enhanced Childhood Cancer Surveillance System. Available online at https://www.canada.ca/en/health-canada/services/publications/science-research-data/cancer-young-people-canada-surveillance-2017.html
Data overview
- Formats
- CSV
- File languages
- English
- Available actions
- Explore table (prepared automatically) · Access original file
Sample rows
The first 10 rows, as CanQuery read them from the start of the publisher's file on 2026-11-11.
| ICCC-3 diagnostic groups and sub-group | OSP (%) | Lower CI (%) | Upper CI (%) |
|---|---|---|---|
| All cancers combined | 81.5 | 80.4 | 82.6 |
| I Leukemias, myeloproliferative diseases, and myelodysplastic diseases | 85.7 | 83.8 | 87.4 |
| I(a) Lymphoid leukemias | 90.2 | 88.3 | 91.8 |
| I(b) Acute myeloid leukemias | 69.2 | 62 | 75.4 |
| I(c) Chronic myeloproliferative diseases | 86.5 | 61.4 | 95.7 |
| I(d) Myelodysplastic syndrome and other myeloproliferative diseases | 54.5 | 40.6 | 66.6 |
| I(e) Unspecified and other specified leukemias | 52.4 | 29.7 | 70.9 |
| II Lymphomas and reticuloendothelial neoplasms | 91.3 | 88.8 | 93.2 |
| II(a) Hodgkin lymphomas | 96.3 | 92.8 | 98.1 |
| II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma) | 83.5 | 77.1 | 88.3 |